Indian Emulsifiers Ltd
Indian Emulsifiers Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
4 of 4 strong
The short version
FY26 revenue growth was lower than previously guided (60% vs expected 100%) due to unforeseen global issues and February-March market panic. - Australia market shipment recently started; targeted revenue of ₹75 crore cumulatively over FY26-FY28 expected. - New American subsidiary set up; contribution to revenue expected from FY27 onwards, targeting oil, gas, and other industries. - Current capacity supports approx. FY26 saw strong growth: Revenue +57%, EBITDA +24.22%, PAT +21.83%.
From Indian Emulsifiers Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- FY26 revenue growth was lower than previously guided (60% vs expected 100%) due to unforeseen global issues and February-March market panic.
- Australia market shipment recently started; targeted revenue of ₹75 crore cumulatively over FY26-FY28 expected.
- New American subsidiary set up; contribution to revenue expected from FY27 onwards, targeting oil, gas, and other industries.
- Current capacity supports approx. ₹230-260 crore revenue; new Greenfield facility (400-500 MT capacity) expected operational by end FY27, boosting capacity.
- Additional adjoining land acquired for QC, R&D, and food-grade emulsifier products with certifications; expected addition by early FY28.
2 more points from Indian Emulsifiers Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Indian Emulsifiers Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is undertaking a Greenfield project on plot C3, expected to be operational by end of FY27, adding 400 to 500 metric tons capacity.
- An adjoining plot was purchased in February to expand QC and R&D facilities and build a food-grade emulsifier facility with required certification; expected online by end FY27 or early FY28.
- The new food-grade facility will add 200 to 250 metric tons of capacity, though exact numbers may vary due to certification.
- Space provisions exist on the new plot to potentially add another 300 to 500 metric tons capacity in the future.
- The rights issue in November funded the upcoming capacity addition and capital expenditure.
2 more points from Indian Emulsifiers Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Indian Emulsifiers Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders in specific numerical terms.
- However, there are references to new business uptake and sales expectations:
- Australia: Expect uptake this year and next with targets of about ₹75 crore cumulative revenue over three years.
- American subsidiary: Started contributing revenue already with expected scaling up in FY27 onwards.
- Capacity expansion is underway to meet growing demand, indicating an anticipation of increased orders.
2 more points from Indian Emulsifiers Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
What Indian Emuls's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Vishnu Chemicals Ltd (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
- Rajputana Bio. (Q4 FY26)
Revenue from Operations: ₹6,267.05 lakhs vs. Key investor presentation takeaways from Rajputana Bio.'s Q4 FY26 investor presentation — and how it ranks against
- Neochem Bio (Q4 FY26)
Capacity utilization improved from ~35% in FY24 to 53% in FY26, with significant headroom (47%) for growth without major capex. Key concall takeaways from…
Arthneeti Pro · Annual
Indian Emulsifiers Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Indian Emulsifiers Ltd Q4 FY26 results?
FY26 revenue growth was lower than previously guided (60% vs expected 100%) due to unforeseen global issues and February-March market panic. - Australia market shipment recently started; targeted revenue of ₹75 crore cumulatively over FY26-FY28 expected. - New American subsidiary set up; contribution to revenue expected from FY27 onwards, targeting oil, gas, and other industries. - Current capacity supports approx. FY26 saw strong growth: Revenue +57%, EBITDA +24.22%, PAT +21.83%.
What is Indian Emulsifiers Ltd share price analysis?
Indian Emulsifiers Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 4.8 with a market cap of ₹78 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indian Emulsifiers Ltd planning capital expenditure?
The company is undertaking a Greenfield project on plot C3, expected to be operational by end of FY27, adding 400 to 500 metric tons capacity.
Keep Indian Emulsifiers Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.